|
“Whether” or never: Reproductive genome editing in humans
Isabelle Bartram, Guest Contributor, Biopolitical Times | 10.10.2023
In the concluding statement of the 2023 international gene editing summit, one little word – “whether” – should be understood as an urgent invitation for civil society to participate vigorously in the debate about the future of germline interventions.
| |
GENE THERAPIES | GENOMICS | EUGENICS
SYNTHETIC EMBRYOS AND STEM CELLS | VARIOUS
| |
Most of today’s gene therapies rely on viruses—and that’s a problem
Tina Hesman Saey, Science News | 10.20.2023
Early gene therapies used retroviruses, which often insert their DNA cargo near active genes. Today, most therapies rely on viruses engineered to deliver their cargo to safer locations and to cause less of an immune response. But still, the track record is far from spotless.
| |
New Trials Aim to Restore Hearing in Deaf Children—With Gene Therapy
Emily Mullin, Wired | 10.20.2023
Two companies have launched clinical trials to test experimental gene therapies that aim to restore hearing to children with a rare type of genetic deafness. Some argue that implanting Deaf children before they have a chance to acquire language denies them autonomy and access to Deaf culture.
| |
Over the counter genetic tests in UK ‘fail to identify 89%’ of those at serious risk
Denis Campbell and Nonyelum Anigbo, The Guardian | 10.17.2023
An in-depth review of polygenic risk scores found that they wrongly tell one in 20 people who receive them they will develop a major illness, even though they do not go on to do so. Further, genetic tests that claim to assess the risk of cancer or heart problems fail to identify 89% of those in danger of developing related diseases.
| |
Do Early R.S.V. Vaccine Trials Have a Henrietta Lacks Story?
Charles M. Blow, The New York Times | 10.11.2023
In the 1960s, some of the first and youngest subjects in a clinical trial to develop R.S.V. vaccines were Black and poor children, some in foster care. Two of them died. Archival documents indicate that their parents did not consent to their children receiving the experimental shot. What are the families of the children involved in those experiments now owed?
| |
23andMe user data targeting Ashkenazi Jews leaked online
Kevin Collier, NBC News | 10.07.2023
Hackers have compiled a giant apparent list of people with Ashkenazi Jewish ancestry taken from 23andMe. The list, which is now being shared on dark web forums, has emerged during a time of increased anti-semitic attacks on Jews in the U.S.
| |
F.D.A. Moves to Regulate Lab Tests That It Says Put Patients ‘at Risk’
Christina Jewett, The New York Times | 09.29.2023
Hundreds of lab tests on the market, including prenatal genetic tests, have very little oversight and may be misleading to the public.The FDA has proposed a rule that would require laboratories conducting these tests to provide data on their accuracy.
| |
‘Techno-Optimism’ is Not Something You Should Believe In
Jag Bhalla and Nathan J. Robinson, Current Affairs | 10.20.2023
Billionaire tech investor Marc Andreessen’s recently published manifesto for “techno-optimism” is just another example of the dangerous TESCREAL bundle of ideologies that come uncomfortably close to those of classical eugenics.
| |
SYNTHETIC EMBRYOS AND STEM CELLS | |
This biotech CEO decided to take her own (fertility) medicine
Antonio Regalado, MIT Technology Review | 10.16.2023
A New York startup is engineering stem cells to craft a “lightweight” version of IVF that they hope will appeal to busy, “professional” women. Critics are skeptical of the procedure’s effectiveness and of the CEO’s exaggerated claims.
| |
What the Law and Bioethics Tell Us About Synthetic Human Embryos
Barbara Pfeffer Billauer, Bill of Health | 10.13.2023
Advances in developing synthetic embryos from pluripotent stem cells demand more consideration of ethical and legal questions related to the regulation of embryo research, ownership over synthetic embryos, and organ transplantation
| |
Japanese scientists race to create human eggs and sperm in the lab
Rob Stein, NPR | 09.28.2023
Japanese scientists who have made advances in IVG acknowledge, “There are so many ethical problems.” Although researchers continue to develop the technique, there is evidence that the Japanese public does not support applications of IVG to fertility.
| |
Gene-edited chickens to combat bird flu: Saviour or liability?
Claire Robinson, GMWatch | 10.19.2023
Scientists at the University of Edinburgh’s Roslin Institute—the animal research center where Dolly the sheep was created—have used CRISPR gene editing to develop chickens resistant to avian flu. But there are serious risks and limitations in the research, which were indicated by the scientists involved but largely ignored or downplayed by mainstream media outlets.
| |
Myopic View of Xenotransplantation
Franklin G. Miller, Hastings Bioethics Forum | 09.25.2023
Xenotransplantation experiments tend to attract media attention, but this coverage obscures the need to support preventive treatments to address chronic disease and distracts from risks of animal exploitation in the experiments.
| | | | |